MetaCap

Vistagen Therapeutics (VTGN) News

NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.1636-0.023 (-12.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VTGN news summary

We found 4 recent headlines mentioning Vistagen Therapeutics (VTGN): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. VTGN is making an outsized move today, down 12.33% at $0.1636, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update", was published by GlobeNewswire on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Vistagen Therapeutics headlines

Stocks mentioned alongside VTGN

Compare VTGN